Literature DB >> 12100200

Cutaneous sarcoidosis successfully treated with topical tacrolimus.

N Katoh1, H Mihara, H Yasuno.   

Abstract

Sarcoidosis is a disorder characterized by macrophage- and T-cell-mediated responses to as yet unidentified infectious antigens or autoantigens. We describe a 62-year-old woman with a 10-year history of orange-yellow plaques of sarcoidosis on her face. Her cutaneous lesions responded to topical tacrolimus ointment after unsuccessful treatment with topical and systemic corticosteroids. No adverse effects were noted with topical tacrolimus in this patient. We discuss the mode of action by which this immunosuppressive agent may act against sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100200     DOI: 10.1046/j.1365-2133.2002.04727.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  [Medium-dose UV-A1 phototherapy. Successful treatment of cutaneous sarcoidosis].

Authors:  N Mahnke; K Medve-Koenigs; M Megahed; N J Neumann
Journal:  Hautarzt       Date:  2003-03-07       Impact factor: 0.751

2.  [Successful topical treatment of cutaneous sarcoidosis with tacrolimus].

Authors:  R Gutzmer; B Völker; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2003-12       Impact factor: 0.751

Review 3.  [Cutaneous manifestations of sarcoidosis].

Authors:  K Amschler; C S Seitz
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

Review 4.  Sarcoidosis and Its Dermatological Manifestations: A Narrative Review.

Authors:  Jancy Koneti; Swathi Priya Cherukuri; Sai Gadde; Revanth Kalluru; Rahul Chikatimalla; Thejaswi Dasaradhan
Journal:  Cureus       Date:  2022-08-16

5.  [Successful treatment of skin and lung sarcoidosis with fumaric acid ester].

Authors:  R Gutzmer; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2004-06       Impact factor: 0.751

6.  Dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids.

Authors:  Shahira Ramadan; Dalia Hossam; Marwah A Saleh
Journal:  Dermatol Pract Concept       Date:  2016-07-31

Review 7.  Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases.

Authors:  Carmen Rodriguez-Cerdeira; Elena Sanchez-Blanco; Alberto Molares-Vila
Journal:  Mediators Inflamm       Date:  2012-11-01       Impact factor: 4.711

8.  Topical pimecrolimus as a new optional treatment in cutaneous sarcoidosis of lichenoid type.

Authors:  Antonella Tammaro; Claudia Abruzzese; Alessandra Narcisi; Giorgia Cortesi; Francesca Romana Parisella; Pier Paolo Di Russo; Gabriella De Marco; Severino Persechino
Journal:  Case Rep Dermatol Med       Date:  2014-02-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.